HighTower Advisors’s iRadimed IRMD Stock Holding History

HighTower Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.97M	Buy	20,441 +78	+0.4%	+$7.8K	﹤0.01%	1723
2025 Q4	$1.98M	Sell	20,363 -19,998	-50%	-$1.72M	﹤0.01%	1672
2025 Q3	$2.87M	Sell	40,361 -20,000	-33%	-$1.33M	﹤0.01%	1437
2025 Q2	$3.61M	Hold	60,361	–	–	﹤0.01%	1242
2025 Q1	$3.17M	Buy	60,361 +361	+0.6%	+$20.3K	﹤0.01%	1270
2024 Q4	$3.3M	Sell	60,000 -22,356	-27%	-$1.18M	﹤0.01%	1244
2024 Q3	$4.14M	Sell	82,356 -20,644	-20%	-$952K	0.01%	1107
2024 Q2	$4.53M	Sell	103,000 -113	-0.1%	-$4.81K	0.01%	1043
2024 Q1	$4.53M	Buy	+103,113	New	+$4.56M	0.01%	1013

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighTower Advisors's IRMD Position: Q1 2026 in Review

HighTower Advisors increased its iRadimed (IRMD) stake by 0.38% in Q1 2026, buying an estimated $7.8K and bringing the position to 20,441 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

HighTower Advisors first reported a position in IRMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.53M in Q1 2024. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

HighTower Advisors held 20,441 shares of iRadimed worth $1.97M as of Q1 2026.
HighTower Advisors bought 78 iRadimed shares in Q1 2026, an estimated $7.8K.
iRadimed made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1723 holding.
HighTower Advisors first reported a position in iRadimed in Q1 2024 and has held it in 9 quarters since.
HighTower Advisors's iRadimed position peaked at $4.53M in Q1 2024.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.